| Foreword |
|
v | |
| Preface |
|
xix | |
|
|
|
xxi | |
| Color Plates |
|
xxvii | |
|
|
|
1 | (82) |
|
Bioinformatics: Data Mining Among Genome Sequences |
|
|
3 | (18) |
|
|
|
|
|
Systematic Genome Analysis of Pathogens as a Basis for Pharmacogenomic Strategies |
|
|
3 | (1) |
|
Direct Sequence Annotation Tools for Functional Genomics |
|
|
4 | (1) |
|
Identification of Protein Function |
|
|
4 | (1) |
|
Obtaining Protein Information from a Domain Server |
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (1) |
|
Adaptation in Time and to Stimuli |
|
|
8 | (5) |
|
Experimental Design for Microarray Analysis |
|
|
8 | (1) |
|
|
|
9 | (4) |
|
Pathogen-Specific Challenges |
|
|
13 | (1) |
|
Pathogen Adaptation Potential |
|
|
14 | (1) |
|
The Fight Against Resistance |
|
|
14 | (1) |
|
Drug Design and Antibiotics |
|
|
15 | (1) |
|
Annotation Platforms Suitable for Pathogenomics |
|
|
15 | (2) |
|
|
|
17 | (4) |
|
Transcriptome Analysis: Towards a Comprehensive Understanding of Global Transcription Activity |
|
|
21 | (22) |
|
|
|
|
|
|
|
21 | (1) |
|
Development of Transcriptomics |
|
|
21 | (2) |
|
From Genomics to Functional Genomics |
|
|
21 | (1) |
|
From Gene to Whole Genome |
|
|
22 | (1) |
|
Introducing the Microarray |
|
|
23 | (2) |
|
|
|
23 | (1) |
|
|
|
23 | (1) |
|
|
|
24 | (1) |
|
|
|
25 | (7) |
|
|
|
25 | (1) |
|
|
|
25 | (3) |
|
|
|
28 | (1) |
|
|
|
28 | (2) |
|
Labeling/Reverse Transcription |
|
|
30 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
Data Normalization and Analysis |
|
|
32 | (5) |
|
|
|
32 | (1) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Detection of Differential Expression |
|
|
34 | (1) |
|
|
|
35 | (1) |
|
Graphical Representations |
|
|
35 | (1) |
|
Microarray Analysis Tools |
|
|
36 | (1) |
|
|
|
36 | (1) |
|
Data Storage and Reanalysis |
|
|
37 | (1) |
|
Transcriptomics: Where We Are Now and What's to Come |
|
|
37 | (6) |
|
Physiological Proteomics of Bacillus subtilis and Staphylococcus aureus: Towards a Comprehensive Understanding of Cell Physiology and Pathogenicity |
|
|
43 | (26) |
|
|
|
|
|
|
|
43 | (3) |
|
Proteomics of Bacillus subtilis: The Gram-positive Model Organism |
|
|
46 | (7) |
|
|
|
46 | (1) |
|
Proteomes of Nongrowing Cells: Proteomic Signatures of Stress/Starvation Stimuli |
|
|
47 | (6) |
|
Physiological Proteomics of Staphylococcus aureus |
|
|
53 | (12) |
|
The Postgenome Era of S. aureus |
|
|
53 | (3) |
|
Proteomes of Growing and Nongrowing Cells |
|
|
56 | (6) |
|
Extracellular Proteins and Pathogenicity Networks |
|
|
62 | (3) |
|
Outlook: Second Generation Proteomics and New Fields in S. aureus Physiology and Infection Biology |
|
|
65 | (4) |
|
Impact of Genome Sequences on Mutational Analysis of Fungal and Bacterial Pathogens |
|
|
69 | (14) |
|
|
|
|
|
The Long Road from Sequence to Function |
|
|
69 | (1) |
|
Classical Genetics Still at the Forefront in the Postgenome Era |
|
|
70 | (2) |
|
|
|
70 | (1) |
|
|
|
71 | (1) |
|
Genome-Scale Mutational Analyses |
|
|
72 | (7) |
|
|
|
73 | (2) |
|
Bacterial Workhorses: E. coli and Bacillus subtilis |
|
|
75 | (1) |
|
|
|
75 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (2) |
|
|
|
79 | (4) |
|
II. Genomics of Pathogenic Bacteria |
|
|
83 | (284) |
|
Pathogenomics of Escherichia coli and Shigella Species |
|
|
85 | (24) |
|
|
|
|
|
|
|
85 | (1) |
|
Comparative Genomics of Shigella |
|
|
86 | (6) |
|
Comparative Genomics of Escherichia coli |
|
|
92 | (9) |
|
Comparison of Complete Genome Sequences |
|
|
92 | (2) |
|
Comparative Genomics Using DNA Arrays |
|
|
94 | (1) |
|
Mobile Genetic Elements and Evolution of Pathogenic E. coli |
|
|
95 | (1) |
|
Genomic Islands/Pathogenicity Islands |
|
|
95 | (4) |
|
Plasmids and Bacteriophages |
|
|
99 | (1) |
|
Genetic Diversity Among Extraintestinal Pathogenic E. coli |
|
|
100 | (1) |
|
|
|
101 | (8) |
|
Pathogenomics of Salmonella Species |
|
|
109 | (16) |
|
|
|
|
|
|
|
109 | (1) |
|
Salmonella Signature Genes |
|
|
109 | (3) |
|
Subspecies I Signature Genes |
|
|
112 | (3) |
|
|
|
115 | (10) |
|
Pathogenomics of Enterococcus faecalis |
|
|
125 | (24) |
|
|
|
|
|
|
|
125 | (1) |
|
Enterococcal Pathogenesis |
|
|
125 | (1) |
|
Genome Sequence of E. faecalis |
|
|
126 | (14) |
|
Mobile Elements, Acquired DNA, and Antimicrobial Resistance |
|
|
127 | (4) |
|
Environmental Adaptation and Stress Response |
|
|
131 | (2) |
|
|
|
133 | (1) |
|
Potential Virulence Factors |
|
|
134 | (1) |
|
Hemolysins, Proteases, and other Enzymes |
|
|
134 | (2) |
|
Cell-Wall-Associated Virulence Factors |
|
|
136 | (2) |
|
Pathogenicity Island of E. faecalis |
|
|
138 | (2) |
|
Conclusions and Future Perspectives |
|
|
140 | (9) |
|
|
|
149 | (26) |
|
|
|
|
|
|
|
149 | (3) |
|
|
|
152 | (10) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
153 | (1) |
|
|
|
154 | (1) |
|
|
|
155 | (1) |
|
Group C (GCS) and Group G Streptococci |
|
|
156 | (1) |
|
|
|
157 | (1) |
|
|
|
157 | (1) |
|
Streptococcus bovis and Streptococcus suis |
|
|
157 | (1) |
|
|
|
158 | (1) |
|
|
|
158 | (1) |
|
Streptococcus mitis, Streptococcus sanguis, and Streptococcus gordonii |
|
|
159 | (1) |
|
Anginosus and Salivarius Group |
|
|
159 | (1) |
|
|
|
159 | (1) |
|
Streptococcus thermophilus |
|
|
160 | (1) |
|
|
|
160 | (1) |
|
Streptococcus mutans and Streptococcus sobrinus |
|
|
160 | (1) |
|
Other Organisms: Enterococcus faecalis |
|
|
161 | (1) |
|
|
|
161 | (1) |
|
Streptococcal Genomic Bacteriophages |
|
|
162 | (13) |
|
Prophages and Streptococcal Genomes |
|
|
162 | (1) |
|
|
|
163 | (1) |
|
Prophages and Virulence Factors |
|
|
163 | (2) |
|
Prophage Attachment Sites and Host Biology |
|
|
165 | (1) |
|
|
|
166 | (1) |
|
Prophages Associated with other Streptococcal Species |
|
|
166 | (9) |
|
Pathogenic Staphylococci: Lessons from Comparative Genomics |
|
|
175 | (36) |
|
|
|
|
|
|
|
|
|
|
|
175 | (1) |
|
Comparative Genomics of S. aureus |
|
|
176 | (19) |
|
|
|
177 | (1) |
|
|
|
178 | (1) |
|
|
|
178 | (2) |
|
|
|
180 | (1) |
|
|
|
181 | (3) |
|
|
|
184 | (1) |
|
|
|
185 | (5) |
|
Staphylococcal Cassette Chromosome |
|
|
190 | (2) |
|
|
|
192 | (2) |
|
|
|
194 | (1) |
|
Staphylococcus epidermidis |
|
|
195 | (7) |
|
|
|
197 | (1) |
|
Phage SPβ and other Bacillus Genes |
|
|
197 | (1) |
|
|
|
197 | (1) |
|
Staphylococcal Cassette Chromosome |
|
|
198 | (1) |
|
Adherence and Biofilm Formation |
|
|
199 | (2) |
|
|
|
201 | (1) |
|
|
|
202 | (9) |
|
Pathogenomics: Insights into Tuberculosis and Related Mycobacterial Diseases |
|
|
211 | (20) |
|
|
|
|
|
|
|
|
|
211 | (1) |
|
Molecular Basis of Pathogenicity |
|
|
212 | (4) |
|
Evolution of the M. tuberculosis Complex |
|
|
216 | (4) |
|
Some Metabolic Insight from the Genome Sequences |
|
|
220 | (2) |
|
Other Major Mycobacterial Human Pathogens |
|
|
222 | (2) |
|
|
|
222 | (1) |
|
|
|
223 | (1) |
|
|
|
224 | (7) |
|
Genomes of Pathogenic Neisseria Species |
|
|
231 | (26) |
|
|
|
|
|
|
|
|
|
|
|
231 | (1) |
|
Genomes of Pathogenic Neisseria Species |
|
|
232 | (17) |
|
|
|
233 | (3) |
|
Repetitive DNA Sequence Elements Govern Neisserial Biology |
|
|
236 | (1) |
|
DNA Uptake Sequences, Horizontal Gene Transfer, and Antigenic Diversity |
|
|
236 | (1) |
|
Simple Sequence Repeats and Phase Variation |
|
|
237 | (1) |
|
Insertion Sequences and the Regulation of Gene Expression |
|
|
238 | (1) |
|
Genome-Wide Mutational Analyses |
|
|
239 | (1) |
|
|
|
240 | (4) |
|
Novel Virulence Factors of Meningococci Identified by Genomic Approaches |
|
|
244 | (5) |
|
|
|
249 | (8) |
|
Genomics of Pathogenic Clostridia and Bacilli |
|
|
257 | (24) |
|
|
|
|
|
|
|
Genomics of Pathogenic Clostridia spp. |
|
|
257 | (8) |
|
|
|
257 | (1) |
|
|
|
258 | (2) |
|
|
|
260 | (2) |
|
|
|
262 | (1) |
|
|
|
263 | (1) |
|
Conclusions and Perspectives |
|
|
264 | (1) |
|
Genomics of Pathogenic Bacilli |
|
|
265 | (16) |
|
|
|
265 | (1) |
|
Pathogenic Properties of Bacilli not Belonging to the B. cereus Group |
|
|
266 | (1) |
|
Pathogenicity of B. cereus |
|
|
266 | (2) |
|
Pathogenicity of B. anthracis |
|
|
268 | (1) |
|
|
|
268 | (1) |
|
Virulence Factors of B. anthracis |
|
|
269 | (1) |
|
|
|
270 | (1) |
|
|
|
270 | (1) |
|
Genes Located on Plasmids pXO1 and pXO2 |
|
|
271 | (1) |
|
Regulation of Virulence Genes |
|
|
272 | (1) |
|
Molecular Diversity in B. anthracis Genomes |
|
|
272 | (1) |
|
Genome of a Highly Virulent B. cereus Strain Resembling B. anthracis in Pathogenesis |
|
|
273 | (1) |
|
Comparison of B. cereus Group Genomes: How Did Pathogenicity Evolve? |
|
|
273 | (8) |
|
The Genomes of Pathogenic Bartonella Species |
|
|
281 | (20) |
|
|
|
|
|
|
|
|
|
281 | (3) |
|
Bartonella in a Phylogenetic Context |
|
|
281 | (1) |
|
Hosts and Vectors for Bartonella Species |
|
|
282 | (2) |
|
Bartonella Species and Pathogenicity |
|
|
284 | (2) |
|
Infection of Reservoir and Incidental Host |
|
|
284 | (1) |
|
Bartonella Species as Human Pathogens |
|
|
285 | (1) |
|
|
|
286 | (1) |
|
Genomic Islands and Phages |
|
|
286 | (1) |
|
Genomic Islands and Phages in Bartonella Species |
|
|
287 | (4) |
|
|
|
288 | (1) |
|
B. henselae Genomic Islands and Islets |
|
|
288 | (2) |
|
B. quintana Harbors Remnants of the B. henselae Islands |
|
|
290 | (1) |
|
Role of Phages and Islands in the Evolution of Bartonella |
|
|
290 | (1) |
|
The Chromosome II-Like Segment in Bartonella |
|
|
291 | (3) |
|
Type IV Secretion Systems in Bartonella Species |
|
|
292 | (1) |
|
|
|
293 | (1) |
|
|
|
293 | (1) |
|
B. quintana's Evolution into a Human Pathogen |
|
|
294 | (1) |
|
Conclusions and Future Perspectives |
|
|
295 | (6) |
|
Pathogenomics of Gastric and Enterohepatic Helicobacter Species |
|
|
301 | (14) |
|
|
|
|
|
|
|
|
|
301 | (1) |
|
|
|
302 | (3) |
|
Key Features of the H. pylori Genome Related to Pathogenesis |
|
|
302 | (1) |
|
Colonization Factors: Urease and Motility |
|
|
302 | (1) |
|
|
|
302 | (1) |
|
The H. pylori Outer Membrane Protein Family |
|
|
303 | (1) |
|
Intraspecies Variation of H. pylori Genomes |
|
|
303 | (1) |
|
The cag Pathogenicity Island |
|
|
304 | (1) |
|
Nucleotide Sequence Variation in H. pylori |
|
|
305 | (1) |
|
|
|
305 | (2) |
|
|
|
306 | (1) |
|
Other Putative H. hepaticus Virulence Factors |
|
|
307 | (1) |
|
Genome Comparisons of Gastric and Enterohepatic Helicobacter Species with Related Bacteria |
|
|
307 | (1) |
|
|
|
308 | (7) |
|
Genomics of the Opportunistic Pathogen Legionella pneumophila |
|
|
315 | (24) |
|
|
|
|
|
The Genus Legionella: Epidemiology, Life Cycle, and Pathogenesis |
|
|
315 | (1) |
|
Genomics of Legionella pneumophila |
|
|
316 | (2) |
|
Specific Features of the Legionella Genomes |
|
|
318 | (15) |
|
Eukaryotic-like Proteins in Legionella pneumophila: Modulation of Host Functions? |
|
|
318 | (6) |
|
Secretion Machineries of L. pneumophila: Central to Its Life and to Pathogenesis |
|
|
324 | (1) |
|
Type IV Secretion Systems in Legionella |
|
|
325 | (1) |
|
The dot/icm Type IVB Secretion System |
|
|
325 | (1) |
|
The Ivh Type IVA Secretion System |
|
|
326 | (1) |
|
A Putative Type I Secretion System in Legionella |
|
|
326 | (1) |
|
A Type II Secretion System in Legionella |
|
|
327 | (1) |
|
Secretion Across the Cytoplasmic Membrane |
|
|
327 | (1) |
|
A Putative Type V Secretion System (Autotransporter) Specific to Strain Paris |
|
|
328 | (1) |
|
Comparative Genomics: Diversity of the Species L. pneumophila |
|
|
329 | (1) |
|
Genomic (Pathogenicity) Islands in the L. pneumophila Genomes |
|
|
329 | (2) |
|
Plasmids and Genetic Diversity of L. pneumophila |
|
|
331 | (2) |
|
|
|
333 | (6) |
|
Genomics of Listeria monocytogenes |
|
|
339 | (28) |
|
|
|
|
|
Introduction: From Pregenomics to Postgenomics |
|
|
339 | (1) |
|
Listeria monocytogenes: A Facultative Intracellular Pathogen |
|
|
339 | (1) |
|
Listeria monocytogenes Genetics in the Pregenomic Era: Identification and Characterization of Important Virulence Factors |
|
|
340 | (6) |
|
Internalins and the Invasion of Nonprofessional Phagocytic Cells |
|
|
340 | (2) |
|
Listeriolysin O and Two Listerial Phospholipases Allow Escape from the Phagocytic Vacuole |
|
|
342 | (1) |
|
Intracellular Motility and Cell-to-Cell Spread: The Surface Protein ActA |
|
|
343 | (1) |
|
PrfA and the Regulation of Virulence Gene Expression |
|
|
344 | (2) |
|
Genome Sequence of L. monocytogenes and Its Comparison with the Closely Related L. innocua |
|
|
346 | (2) |
|
Genomic Approaches to Studying the other Members of the Genus Listeria |
|
|
348 | (1) |
|
|
|
349 | (2) |
|
Identification of Listerial Virulence Factors in the Postgenomic Era |
|
|
351 | (4) |
|
Internalins and Other Surface Proteins |
|
|
351 | (1) |
|
Growth in the Host Cell Cytoplasm |
|
|
352 | (1) |
|
|
|
353 | (1) |
|
Two-component Systems and the Regulation of Virulence Gene Expression |
|
|
354 | (1) |
|
Vitamin B12 Biosynthesis and Anaerobic Use of Ethanolamine |
|
|
354 | (1) |
|
|
|
355 | (1) |
|
|
|
356 | (2) |
|
|
|
358 | (9) |
|
III. Genomics of Pathogens and Their Hosts: Applications |
|
|
367 | (188) |
|
|
|
369 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Introduction: Wide Scope of Virogenomics |
|
|
369 | (2) |
|
|
|
371 | (3) |
|
Applications of Data Banks to Virology |
|
|
374 | (5) |
|
Beyond Reference Strains: Towards a Second-Generation Virogenomics? |
|
|
379 | (3) |
|
Virogenomics Through Microarrays |
|
|
382 | (7) |
|
Genomics of Pathogenic Fungi |
|
|
389 | (28) |
|
|
|
|
|
|
|
|
|
|
|
389 | (1) |
|
Genomics of Primary Fungal Pathogens |
|
|
390 | (7) |
|
|
|
390 | (6) |
|
|
|
396 | (1) |
|
Blastomyces and Paracoccidioides |
|
|
396 | (1) |
|
Genomics of Opportunistic Fungal Pathogens |
|
|
397 | (9) |
|
|
|
397 | (1) |
|
|
|
398 | (3) |
|
|
|
401 | (1) |
|
|
|
402 | (1) |
|
|
|
403 | (3) |
|
The Tool Box for Functional Genomics |
|
|
406 | (4) |
|
|
|
407 | (1) |
|
Transformation and Mutagenesis |
|
|
407 | (3) |
|
Fungal Virulence -- From the Genomic Point of View |
|
|
410 | (1) |
|
|
|
411 | (6) |
|
Genomics of Pathogenic Parasites |
|
|
417 | (28) |
|
|
|
|
|
Exploring the Genomes of Pathogenic Protozoans |
|
|
418 | (2) |
|
The Shaping of the Proteomes of the Pathogenic Protists |
|
|
420 | (1) |
|
Role of Horizontal Gene Transfer in Protozoan Genome Plasticity |
|
|
421 | (1) |
|
|
|
422 | (7) |
|
Plasmodium, the Malaria Parasite |
|
|
423 | (4) |
|
|
|
427 | (1) |
|
|
|
428 | (1) |
|
The Pathogenic Kinetoplastids |
|
|
429 | (2) |
|
|
|
430 | (1) |
|
|
|
431 | (1) |
|
The Pathogenic Diplomanad Giardia and the Parabasalid Trichomonas |
|
|
431 | (2) |
|
Postgenomic Strategies and the Search for Cure |
|
|
433 | (12) |
|
|
|
434 | (1) |
|
|
|
434 | (1) |
|
Drug and Vaccine Development |
|
|
435 | (1) |
|
|
|
436 | (9) |
|
Model Host Systems: Tools for Comprehensive Analysis of Host-Pathogen Interactions |
|
|
445 | (12) |
|
|
|
|
|
|
|
445 | (1) |
|
Host-Pathogen Interactions |
|
|
446 | (1) |
|
Arabidopsis thaliana: A Plant as a Model for Human Disease |
|
|
447 | (1) |
|
Dictyostelium discoideum: Perspectives from a Social Amoeba |
|
|
448 | (1) |
|
Caenorhabditis elegans: Answers from a Worm |
|
|
449 | (1) |
|
Drosophila melanogaster: A Fruitful Model |
|
|
450 | (1) |
|
Danio rerio: Fishing for Knowledge |
|
|
451 | (1) |
|
Mus musculus: Of Mice and Men |
|
|
451 | (2) |
|
Clean Models and Dirty Reality |
|
|
453 | (4) |
|
Expression Analysis of Human Genes During Infection |
|
|
457 | (24) |
|
|
|
|
|
|
|
457 | (1) |
|
Comparison of Gene Expression Profiles of Macrophages and Dendritic Cells In Vitro Upon Infection with Different Pathogens |
|
|
458 | (2) |
|
|
|
460 | (1) |
|
Gene Expression in Epithelial Cells Modulated by Bacteria |
|
|
461 | (8) |
|
|
|
462 | (2) |
|
|
|
464 | (2) |
|
|
|
466 | (2) |
|
|
|
468 | (1) |
|
|
|
469 | (2) |
|
Genetic Polymorphisms and Mutations Affect Gene Expression: Impact on Infection Susceptibility and Infection Course |
|
|
471 | (2) |
|
|
|
473 | (8) |
|
Pathogenomics: Application and New Diagnostic Tools |
|
|
481 | (24) |
|
|
|
|
|
Introduction: ``In Our Hands'' |
|
|
481 | (1) |
|
Microbiological Diagnostics of Bacterial Pathogens: Aims, Tasks, and Current Limitations |
|
|
482 | (1) |
|
The Pregenomic Era: Conventional and Molecular Methods in Microbiological Diagnostics |
|
|
483 | (4) |
|
Conventional Culture-Based Methods in Microbiological Diagnostics |
|
|
483 | (1) |
|
Molecular Microbiological Diagnostic Methods |
|
|
484 | (1) |
|
Typing of Bacterial Isolates Using 16S-rRNA |
|
|
484 | (1) |
|
Fluorescence In Situ Hybridization |
|
|
484 | (1) |
|
PCR Methods for Microbial Diagnostics |
|
|
485 | (2) |
|
The Postgenomic Era: Use of DNA Microarrays in the Diagnosis of Infectious Diseases in Humans and Animals |
|
|
487 | (8) |
|
DNA Arrays: Platforms, Techniques and Targets |
|
|
487 | (1) |
|
Detection and Typing of Microbial Pathogens |
|
|
488 | (1) |
|
|
|
489 | (5) |
|
|
|
494 | (1) |
|
Detection of Antibiotic Resistance in Microbial Pathogens Using Microarray Technology |
|
|
494 | (1) |
|
Microarray Technology in Bacteria: Further Areas of Applications |
|
|
495 | (3) |
|
Gene Expression Microarrays and Host-Pathogen Interaction |
|
|
495 | (1) |
|
DNA Microarray Technology in Food Technology |
|
|
496 | (1) |
|
DNA Microarray Technology in Environmental Microbiology |
|
|
496 | (1) |
|
Pathogenomic Tools (Microarrays) in the Diagnosis of Microbiologic Agents as Biovyeapons |
|
|
497 | (1) |
|
Current Limitations on the Use of DNA Microarrays in Diagnostics in Medical Microbiological Laboratories |
|
|
498 | (1) |
|
|
|
498 | (7) |
|
The Search for New Antibiotics |
|
|
505 | (28) |
|
|
|
|
|
|
|
The Need for Novel Antibiotics |
|
|
505 | (2) |
|
Where Will the New Antibiotics Come From? |
|
|
507 | (6) |
|
|
|
507 | (2) |
|
|
|
509 | (2) |
|
|
|
511 | (2) |
|
Contributions of Genomic Technologies to Antibacterial Research |
|
|
513 | (8) |
|
Target Identification and Validation |
|
|
513 | (4) |
|
|
|
517 | (1) |
|
Genetic Tools for Drug Screening and Mode-of-Action Determination |
|
|
517 | (3) |
|
Genome-Wide Expression Profiling for Mode-of-Action Characterization |
|
|
520 | (1) |
|
Outlook for Genomic Technologies for Antibiotic Drug Discovery |
|
|
521 | (1) |
|
Alternative Approaches in Antibacterial Drug Discovery |
|
|
521 | (12) |
|
Targeting the Resistance Mechanism |
|
|
522 | (1) |
|
Extremely Narrow-Spectrum Drugs |
|
|
523 | (1) |
|
Phage Therapies and other Bacteriolytic Approaches |
|
|
524 | (1) |
|
Strategies for Reducing Virulence and/or Influencing Pathogenesis |
|
|
525 | (8) |
|
Reverse Vaccinology: Revolutionizing the Approach to Vaccine Design |
|
|
533 | (22) |
|
|
|
|
|
|
|
Impact of Genomics on Vaccine Design |
|
|
533 | (2) |
|
MenB Vaccine Approach by Reverse Vaccinology |
|
|
535 | (3) |
|
Following the MenB Experience: Other Pathogens |
|
|
538 | (1) |
|
|
|
539 | (1) |
|
Gene Expression In Vivo: IVET and STM |
|
|
540 | (1) |
|
Transcriptome Analysis and Comparative Genomics |
|
|
541 | (5) |
|
Proteomics and Vaccine Design |
|
|
546 | (1) |
|
|
|
546 | (9) |
| Index |
|
555 | |